Overview
Lenaig Donval-Abily practices in Rouen, France. Donval-Abily is rated as an Experienced expert by MediFind in the treatment of Mucopolysaccharidoses (MPS). Their top areas of expertise are Malonyl-CoA Decarboxylase Deficiency, Mucopolysaccharidoses (MPS), Metabolic Acidosis, and Fabry Disease.
Their clinical research consists of co-authoring 22 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Mucopolysaccharidoses (MPS).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Malonyl-CoA Decarboxylase DeficiencyDonval-Abily isAdvanced. Learn about Malonyl-CoA Decarboxylase Deficiency.
- Experienced
- Fabry DiseaseDonval-Abily isExperienced. Learn about Fabry Disease.
- Intraventricular Hemorrhage of the NewbornDonval-Abily isExperienced. Learn about Intraventricular Hemorrhage of the Newborn.
- Metabolic AcidosisDonval-Abily isExperienced. Learn about Metabolic Acidosis.
- Mucopolysaccharidoses (MPS)Donval-Abily isExperienced. Learn about Mucopolysaccharidoses (MPS).
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)
- Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome)